Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/eurheartj/ehaa873 | DOI Listing |
ESC Heart Fail
January 2025
Mid-Atlantic Permanente Research Institute, Mid-Atlantic Permanente Medical Group, Washington, DC, USA.
Aims: Guideline-directed medical therapy (GDMT) is recommended for all patients with heart failure with reduced ejection fraction (HFrEF). Despite this, little data exist describing GDMT use in diverse, real-world populations including the use of vasodilators, prescribed primarily to Black populations. We sought, among a diverse population of HFrEF patients, to determine (1) GDMT use rates and target dosing by medication class and (2) predictors of GDMT use and target dosing by medication class.
View Article and Find Full Text PDFChest
January 2025
Liverpool School of Tropical Medicine, Liverpool, England.
Open Respir Arch
November 2024
Translational Research In Airway Diseases Group (TRIAD), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Zhonghua Yi Xue Za Zhi
December 2024
Heart Center, Beijing key laboratory of hypertension research, Beijing Chaoyang Hospital, Capital Medical University, Beijing100020, China.
ESC Heart Fail
November 2024
Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Aims: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are prevalent comorbidities associated with significant morbidity/mortality. We assessed prevalence of, patient profiles and outcomes associated with COPD across the ejection fraction (EF) spectrum.
Methods: HF patients enrolled in the Swedish HF registry between 2005 and 2021 were considered.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!